Always‑Ready PV Framework
A Modern Approach to Pharmacovigilance System Governance
1. What the Always‑Ready PV Framework Is
The Always‑Ready PV Framework is a structured approach to pharmacovigilance system governance designed to ensure inspection readiness year-round through clarity, control, and confidence.
2. What Regulators Expect
Regulators increasingly assess whether organisations understand how their pharmacovigilance system operates in practice, can demonstrate clear ownership and escalation, maintain consistent MAH oversight across vendors, and document decisions coherently.
3. Common Weaknesses We See
Across inspections, we routinely observe fragmented governance, unclear delegated responsibilities, mismatches between documented and operational systems, scattered evidence, and PSMFs that do not reflect reality.
4. What the Framework Delivers
This framework delivers clear system maps and RACIs, a predictable governance cadence, aligned vendor oversight, coherent inspection narratives, and sustainable, defensible compliance, all of which can significantly benefit companies seeking pharmacovigilance consulting.
Our Services
We offer services based on your journey. Discover our services based on your needs and inspection status (whether announced/confirmed or not).
Inspection Readiness
A Complete Guide for EMA, MHRA & FDA Expectations
1. What the Always‑Ready PV Framework Is
The Always‑Ready PV Framework is a structured approach to pharmacovigilance system governance designed to ensure inspection readiness year-round through clarity, control, and confidence.
2. What Regulators Expect
Regulators increasingly assess whether organisations understand how their pharmacovigilance system operates in practice, can demonstrate clear ownership and escalation, maintain consistent MAH oversight across vendors, and document decisions coherently.
3. Common Weaknesses We See
Across inspections, we routinely observe fragmented governance, unclear delegated responsibilities, mismatches between documented and operational systems, scattered evidence, and PSMFs that do not reflect reality.
4. What the Framework Delivers
This framework delivers clear system maps and RACIs, a predictable governance cadence, aligned vendor oversight, coherent inspection narratives, and sustainable, defensible compliance, all of which can significantly benefit companies seeking pharmacovigilance consulting.
Our Approach
Whether you are expecting an inspection or not, inspection readiness starts with you. From process and system designs to improvements, evaluate your level of compliance now.
Vendor Oversight & Governance
How to Build a High‑Control, Low‑Friction Oversight Model
1. What the Always‑Ready PV Framework Is
The Always‑Ready PV Framework is a structured approach to pharmacovigilance system governance designed to ensure inspection readiness year-round through clarity, control, and confidence.
2. What Regulators Expect
Regulators increasingly assess whether organisations understand how their pharmacovigilance system operates in practice, can demonstrate clear ownership and escalation, maintain consistent MAH oversight across vendors, and document decisions coherently.
3. Common Weaknesses We See
Across inspections, we routinely observe fragmented governance, unclear delegated responsibilities, mismatches between documented and operational systems, scattered evidence, and PSMFs that do not reflect reality.
4. What the Framework Delivers
This framework delivers clear system maps and RACIs, a predictable governance cadence, aligned vendor oversight, coherent inspection narratives, and sustainable, defensible compliance, all of which can significantly benefit companies seeking pharmacovigilance consulting.
Control review
End-to-end process review allows a holistic evaluation of your system for strong governance and compliance.
PSMF Guide
Clarity, Coherence & Operational Reality
1. What the Always‑Ready PV Framework Is
The Always‑Ready PV Framework is a structured approach to pharmacovigilance system governance designed to ensure inspection readiness year-round through clarity, control, and confidence.
2. What Regulators Expect
Regulators increasingly assess whether organisations understand how their pharmacovigilance system operates in practice, can demonstrate clear ownership and escalation, maintain consistent MAH oversight across vendors, and document decisions coherently.
3. Common Weaknesses We See
Across inspections, we routinely observe fragmented governance, unclear delegated responsibilities, mismatches between documented and operational systems, scattered evidence, and PSMFs that do not reflect reality.
4. What the Framework Delivers
This framework delivers clear system maps and RACIs, a predictable governance cadence, aligned vendor oversight, coherent inspection narratives, and sustainable, defensible compliance, all of which can significantly benefit companies seeking pharmacovigilance consulting.
Be Ready
Start with a quick snap shot review of the document to assess areas of improvements and risks straight away.